Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sofia Antoniou"'
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Nivolumab is an anti-programmed cell death protein 1 antibody, typically used as cancer immunotherapy agent. Despite multiple clinical benefits it might cause autoimmune-related side-effects, often involving the endocrine system.
Externí odkaz:
https://doaj.org/article/146dd2221e804cf88b9a8f1a66e869fd
Autor:
Sofia Antoniou, Katerina K. Naka, Marios Papadakis, Aris Bechlioulis, Dimitrios Makriyiannis, Agathocles Tsatsoulis, Lampros K. Michalis, Stelios Tigas
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 12, p 185 (2021)
The aim of this study was to assess the factors associated with impaired vascular function in patients with poorly controlled type 2 diabetes (DM2) with and without overt cardiovascular disease (CVD). Ninety-five patients with DM2 and poor glycemic c
Externí odkaz:
https://doaj.org/article/cbdb01951c87429493dc03722a0d07e1
Autor:
Marios Papadakis, Sofia Antoniou, Katerina K. Naka, Agathocles Tsatsoulis, Stelios Tigas, Lampros K. Michalis, Aris Bechlioulis
Publikováno v:
World Journal of Diabetes
Cardiovascular disease is the predominant cause of death in type 2 diabetes mellitus (T2DM). Evidence suggests a strong association between duration and degree of hyperglycemia and vascular disease. However, large trials failed to show cardiovascular
Autor:
Oana Patricia Zaharia, Martin Schön, Luca Löffler, Klaus Strassburger, Clara Möser, Iryna Yurchenko, Kálmán Bódis, Sofia Antoniou, Yanislava Karusheva, Julia Szendroedi, Volker Burkart, Michael Roden
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(10)
Context Endothelial dysfunction may occur early in the development of cardiovascular and metabolic diseases; however, it remains often underestimated and studies rarely discriminate between diabetes types. We have examined endothelial function and it
Autor:
Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig, Jong-Hee Hwang, Olof Asplund, Leif Groop, Emma Ahlqvist, Jochen Seissler, Peter Nawroth, Stefan Kopf, Sebastian M Schmid, Michael Stumvoll, Andreas F H Pfeiffer, Stefan Kabisch, Sergey Tselmin, Hans U Häring, Dan Ziegler, Oliver Kuss, Julia Szendroedi, Michael Roden, Bengt-Frederik Belgardt, Anette Buyken, Jürgen Eckel, Gerd Geerling, Hadi Al-Hasani, Christian Herder, Andrea Icks, Jörg Kotzka, Eckart Lammert, Daniel Markgraf, Wolfgang Rathmann
Publikováno v:
The Lancet Diabetes & Endocrinology. 7:684-694
Summary Background Cluster analyses have proposed different diabetes phenotypes using age, BMI, glycaemia, homoeostasis model estimates, and islet autoantibodies. We tested whether comprehensive phenotyping validates and further characterises these c
Publikováno v:
BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-6 (2021)
Background Nivolumab is an anti-programmed cell death protein 1 antibody, typically used as cancer immunotherapy agent. Despite multiple clinical benefits it might cause autoimmune-related side-effects, often involving the endocrine system. To our kn
Autor:
Katerina K. Naka, Sofia Antoniou, Stelios Tigas, Agathocles Tsatsoulis, Marios Papadakis, Lampros K. Michalis, Aris Bechlioulis
Publikováno v:
Hormones (Athens, Greece). 20(4)
The aim of the present study was to investigate the effect of intensive antidiabetic therapy on vascular indices in type 2 diabetes mellitus (T2DM) patients. Poorly controlled T2DM patients (n = 62, mean age 64 years, T2DM duration 14 years, HbA1c
Autor:
Agathocles Tsatsoulis, Stelios Tigas, Marios Papadakis, Aris Bechlioulis, Katerina K. Naka, Lampros K. Michalis, Dimitrios Makriyiannis, Sofia Antoniou
Publikováno v:
Endocrine Abstracts.
Autor:
Oana P. Zaharia, Oliver Kuss, Olof Asplund, Yanislava Karusheva, Leif Groop, Michael Roden, Julia Szendroedi, Klaus Strassburger, Kálmán Bódis, Karsten Muessig, Yuliya Kupriyanova, Sofia Antoniou, Volker Burkart, Emma Ahlqvist, Jong-Hee Hwang
Publikováno v:
Diabetes. 68
Cluster analysis using age, BMI, glycemia and homeostasis model estimates (HOMA-IR, -B) revealed distinct risk profiles for progression of diabetic nephropathy in large cohorts, but its relevance for other diabetes-related comorbidities remains uncle
Autor:
Karsten Muessig, Julia Szendroedi, Michael Roden, Oana P. Zaharia, Yanislava Karusheva, Birgit Knebel, Sofia Antoniou, Juliane Maria Ahlers, Yuliya Kupriyanova, Jong-Hee Hwang, Daniel F. Markgraf, Volker Burkart, Hadi Al-Hasani, Kálmán Bódis
Publikováno v:
Diabetes. 68
Knockdown of the gene encoding transmembrane 6 superfamily member 2 protein (TM6SF2) in mice increases hepatocellular lipid content (HCL) and decreases very low-density lipoprotein secretion. Humans with TM6SF2 mutations are at higher risk of nonalco